Advertisement
Screener

ADMA BIOLOGICS, INC. (ADMA) Graph

2.8 / 5 stars · 68/120 Roast Me

ADMA Revenue Flow

ADMA Graph summary

ADMA BIOLOGICS, INC. (ADMA). Quarter ended 2026-06-30. Reported revenue sources, expenses and earnings; undisclosed amounts are not inferred.

How ADMA BIOLOGICS, INC. made money in the latest quarterLatest-quarter revenue sources flow through cost of revenue, gross profit, operating expenses, tax, and net income. $0.12B $0.04B$0.09B$0.09B $0.03B$0.05B$0.01B$0.03B$0.00B$0.05B$0.00B$0.01B$0.04B Revenue from contracts with customers, excluding assessed tax$0.12BDeclared revenue$0.12BDeclared cost of revenue$0.04BDeclared gross profit$0.09B Total gross profit$0.09BOperating expenses$0.03BOperating income$0.05BResearch and development$0.01BSelling, general and administrative$0.03BDepreciation, depletion and amortization$0.00BOther expense, net$0.00BPre-tax income$0.05BIncome tax$0.01BNet income$0.04B

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
BIOCRYST PHARMACEUTICALS INC (BCRX)United States$2.175B-6.63
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Vericel Corp (VCEL)United States$2.011B93.97
Greenland Mines Ltd (GRML)United States$2.362B
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
NOVAVAX INC (NVAX)United States$1.748B-6.26
Beam Therapeutics Inc. (BEAM)United States$2.549B-41.51
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Advertisement